Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Mai 2022 13:08 ET | Quelle: CB Therapeutics

CB Therapeutics granted a new patent that will help further provide eco-conscious avenues for psychedelic research

CARLSBAD, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- CB Therapeutics (the “Company”), a biotechnology and precision fermentation company focused on using cellular agriculture to produce...
25. April 2022 08:18 ET | Quelle: CB Therapeutics

CB Therapeutics rapidly expands cellular agriculture capabilities at new facility

CARLSBAD, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- CB Therapeutics (the “Company”), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human...
20. Dezember 2021 08:08 ET | Quelle: CB Therapeutics

Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities

SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board. Dr. Wright...
09. Dezember 2021 13:11 ET | Quelle: CB Therapeutics

CB Therapeutics and atai Life Sciences launch TryptageniX to sustainably supply and develop clinically relevant compounds to tackle the growing mental health crisis

SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics, a biosynthesis company focused on creating ethical and environmentally-friendly products to improve mental health and increase...